Clinical and Experimental Hypertension 1998-01-01

Proscillaridin A immunoreactivity: its purification, transport in blood by a specific binding protein and its correlation with blood pressure.

R Schneider, R Antolovic, H Kost, B Sich, U Kirch, M Tepel, W Zidek, W Schoner

Index: Clin. Exp. Hypertens. 20(5-6) , 593-9, (1998)

Full Text: HTML

Abstract

A material crossreacting with antibodies against the bufadienolide proscillaridin A and inhibiting the sodium pump was found in human blood plasma. The concentration of the material with a retention time similar to ouabain in a reversed phase HPLC correlated to systolic blood pressure and pulse pressure. Affinity purification of this compound from bovine adrenals resulted in the isolation of a compound with molecular mass of 600 Da that was not identical with ouabain. Consistent with the postulate that endogenous ouabain and proscillaridin A immunoreactivities may belong to a new class of cardiotonic steroid hormones, a protein of Mr = 60 kDa has been found in bovine serum by affinity-labeling with N-hydroxysuccimidyl digoxigenin-3-O-methylcarbonyl-epsilon-aminocaproate.


Related Compounds

Related Articles:

Pulse pressure correlates in humans with a proscillaridin A immunoreactive compound.

1996-05-01

[Hypertension 27(5) , 1073-8, (1996)]

Cytotoxic effects of cardiac glycosides in colon cancer cells, alone and in combination with standard chemotherapeutic drugs.

2009-11-01

[J. Nat. Prod. 72 , 1969-74, (2009)]

Role of endogenous cardiac glycosides in the spontaneously hypertensive rat--antagonism by active immunization.

1996-01-01

[Am. J. Hypertens. 9(1) , 81-5, (1996)]

Specific anti-digoxin Fab fragments: an available antidote for proscillaridin and scilliroside poisoning?

1990-05-01

[Hum. Exp. Toxicol. 9(3) , 191-3, (1990)]

Studies on cardiac ingredients of plants. IX. Chemical transformation of proscillaridin by utilizing its 1,4-cycloadducts as key compounds and biological activities of their derivatives.

1992-02-01

[Chem. Pharm. Bull. 40(2) , 327-32, (1992)]

More Articles...